Clinical Trials Directory

Trials / Completed

CompletedNCT01130948

Sleep, Breathing and Psychomotor Performance at Altitude: A Physiologic Study in Healthy Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study investigates the effect of altitude exposure on sleep, breathing and psychomotor performance in healthy subjects.

Detailed description

Sleep is essential for well being and performance. Sleep disturbances by recurrent apnea and hypoxia in patients with obstructive sleep apnea syndrome impair quality of life, cognitive and cardiovascular functions. Similar consequences occur in healthy subjects exposed to hypoxia at altitude due to periodic breathing with recurrent central apnea. This project will investigate effects of altitude on sleep, breathing, psychomotor performance and on the cardiovascular system in healthy subjects and patients with sleep apnea. The results will help to better understand mechanisms of sleep disturbances and psychomotor impairment induced by hypoxia and to prevent adverse effects of altitude exposure.

Conditions

Interventions

TypeNameDescription
OTHERaltitude exposureexposure to 490m, 1700m and 2590m

Timeline

Start date
2010-05-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2010-05-26
Last updated
2014-05-20

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01130948. Inclusion in this directory is not an endorsement.

Sleep, Breathing and Psychomotor Performance at Altitude: A Physiologic Study in Healthy Subjects (NCT01130948) · Clinical Trials Directory